步长制药：全资子公司山东丹红签订药品注册临床试验委托合同

Company Overview - Shandong Buchang Pharmaceutical Co., Ltd. announced a contract with Beijing Excellent Future International Pharmaceutical Technology Development Co., Ltd. for the clinical trial registration of the product "Shenfu Yixin Granules" [1] - The company's market capitalization is currently 18.1 billion yuan [1] Financial Performance - For the year 2024, the revenue composition of Buchang Pharmaceutical is as follows: 99.71% from the pharmaceutical industry and 0.29% from other businesses [1]